Home » Topics » BioWorld Science

BioWorld Science
RSS

Getting at stored mRNAs part of fragile X problem

Aug. 21, 2018

Common pathway may underlie schizophrenia and PD

Aug. 21, 2018

Harbour BioMed licenses ex-China rights to Kelun-Biotech's A-167

Aug. 21, 2018

Polymorphisms in miRNA-146a and IRAK1 are associated with susceptibility to SLE and MS

Aug. 21, 2018

Adipose-derived regenerative cell therapy safe in patients with erectile dysfunction

Aug. 21, 2018

Celleron enrolls first patient in phase Ib/II study of CXD-101 with nivolumab for colorectal cancer

Aug. 20, 2018

European clearance for phase II study of SENS-401 for sudden sensorineuronal hearing loss

Aug. 20, 2018

FDA approves Eylea injection sBLA in wet AMD

Aug. 20, 2018

Let there be no light damage

Aug. 20, 2018

Vaccinations initiated in first-in-human trial of novel attenuated Zika vaccine

Aug. 20, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...